Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated Adults
Study sponsor: Emergent BioSolutions
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2003-04Actual
Enrollment · participants357Actual
Source updated2024-03-18Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.